The anti-EGFRvIII-CD3ζ-TIR-CAR-iMACs demonstrated alleviated tumor progression and prolonged survival in orthotopic glioblastoma mouse models with U87MGEGFRvIII cells in comparison to first-generation anti-EGFRvIII-CAR-iMACs. The gene discussed is CD247; the disease is neoplasm.